122 related articles for article (PubMed ID: 22968906)
1. Targeting hedgehog-GLI-2 pathway in osteosarcoma.
Yang W; Liu X; Choy E; Mankin H; Hornicek FJ; Duan Z
J Orthop Res; 2013 Mar; 31(3):502-9. PubMed ID: 22968906
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion.
Nagao-Kitamoto H; Setoguchi T; Kitamoto S; Nakamura S; Tsuru A; Nagata M; Nagano S; Ishidou Y; Yokouchi M; Kitajima S; Yoshioka T; Maeda S; Yonezawa S; Komiya S
Cancer Lett; 2015 Jan; 356(2 Pt B):855-61. PubMed ID: 25449781
[TBL] [Abstract][Full Text] [Related]
6. Role of GLI2 in the growth of human osteosarcoma.
Nagao H; Ijiri K; Hirotsu M; Ishidou Y; Yamamoto T; Nagano S; Takizawa T; Nakashima K; Komiya S; Setoguchi T
J Pathol; 2011 Jun; 224(2):169-79. PubMed ID: 21506130
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between Hh and Wnt signaling promotes osteosarcoma progression.
Xu Y; Yu P; Wang S; Jiang L; Chen F; Chen W
Int J Clin Exp Pathol; 2019; 12(3):768-773. PubMed ID: 31933884
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic relevance of PRAME in primary osteosarcoma.
Tan P; Zou C; Yong B; Han J; Zhang L; Su Q; Yin J; Wang J; Huang G; Peng T; Shen J
Biochem Biophys Res Commun; 2012 Mar; 419(4):801-8. PubMed ID: 22390931
[TBL] [Abstract][Full Text] [Related]
9. Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines.
Perez J; Bardin C; Rigal C; Anthony B; Rousseau R; Dutour A
Anticancer Res; 2011 Sep; 31(9):2813-20. PubMed ID: 21868524
[TBL] [Abstract][Full Text] [Related]
10. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.
Nathan SS; DiResta GR; Casas-Ganem JE; Hoang BH; Sowers R; Yang R; Huvos AG; Gorlick R; Healey JH
Clin Cancer Res; 2005 Mar; 11(6):2389-97. PubMed ID: 15788690
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide overload increases adriamycin-induced apoptosis of SaOS(2)FM, a manganese superoxide dismutase-overexpressing human osteosarcoma cell line.
Wang Y; Kuroda M; Gao XS; Asaumi J; Shibuya K; Kawasaki S; Akaki S; St Clair D; Hiraki Y; Kanazawa S
Int J Oncol; 2005 May; 26(5):1291-300. PubMed ID: 15809720
[TBL] [Abstract][Full Text] [Related]
12. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
13. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
Rainusso N; Brawley VS; Ghazi A; Hicks MJ; Gottschalk S; Rosen JM; Ahmed N
Cancer Gene Ther; 2012 Mar; 19(3):212-7. PubMed ID: 22173710
[TBL] [Abstract][Full Text] [Related]
15. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin.
Chakkalakal DA; Mollner TJ; Bogard MR; Fritz ED; Novak JR; McGuire MH
Cancer Biochem Biophys; 1999 Jul; 17(1-2):89-98. PubMed ID: 10738905
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
17. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
[TBL] [Abstract][Full Text] [Related]
18. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
[TBL] [Abstract][Full Text] [Related]
19. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
20. SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.
Lézot F; Corre I; Morice S; Rédini F; Verrecchia F
Cells; 2020 Feb; 9(3):. PubMed ID: 32110934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
